DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.
Bracht
Lynn-Kristin
LK
Center for Neuro-Oncology, Boston, MA, USA.
Wen
Patrick
P
Meyerhardt
Jeffrey A
JA
Kulke
Matthew H
MH
Hornick
Jason L
JL
Redston
Mark
M
LaFrankie
Debra Conrad
DC
Black
Peter M
PM
Kesari
Santosh
S
Norden
Andrew
A
Drappatz
Jan
J
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000378:metabolism / Q000628:therapy*; D003131:Combined Modality Therapy; D045643:DNA Repair Enzymes / Q000096:biosynthesis*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018450:Disease Progression; D017809:Fatal Outcome; D005909:Glioblastoma / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000150:complications / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D045643:DNA Repair Enzymes; D000077204:Temozolomide